About

Name

Glen Baker

University

University of Alberta

Website

psychiatry.med.ualberta.ca/AboutUs/DepartmentMembers/Academic/Baker.aspx

Email

[email protected]

Research Keywords

biomarkers in psychiatric and neurological disorders, neurochemistry of depression, schizophrenia and anxiety disorders, drug metabolism and drug interactions, neuroprotective drugs

Additional Information

Lab Methodologies
  • Neurosteroid Assays
  • Amino acid detection
  • Biogenic amines and metabolites including trace amines
  • Radiochemical lab
Apparatus
  • HPLC (fluorimetry, electrochemical, UV detection)
  • HPLC Mass Spectrometry
  • Gas Chromatography Electron Capture detector
  • Gas Chromatography Mass Spectrometry including Triple Quad
  • Liquid Scintillation Counter

 

Roles and Connections

Primary Role

Faculty

CAN Connections

Depression

Most Cited Publications

Asahchop EL, Meziane O, Mamik MK, Chan WF, Branton WG, Resch L, Gill MJ, Haddad E, Guimond JV, Wainberg MA, Baker GB, Cohen EA, Power C, "Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain." Retrovirology 14,1 (2017 Oct 16): 47
Noorbakhsh F, Baker GB, Power C, "Allopregnanolone and neuroinflammation: a focus on multiple sclerosis." Frontiers in cellular neuroscience 8, (2014): 134
Potter LE, Paylor JW, Suh JS, Tenorio G, Caliaperumal J, Colbourne F, Baker G, Winship I, Kerr BJ, "Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis." Journal of neuroinflammation 13,1 (2016 Jun 10): 142